HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheng Huang Selected Research

ErbB Receptors (EGF Receptor)

1/2021Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
1/2021Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.
12/2020Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II-IIIA (N1-N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) study.
10/2020Knockdown of Amphiregulin Triggers Doxorubicin-Induced Autophagic and Apoptotic Death by Regulating Endoplasmic Reticulum Stress in Glioblastoma Cells.
1/2019Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study.
1/2017Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
3/2014A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805).
9/2013[The efficacy and adverse effects of individualized treatment for elderly patients with epidermal growth factor receptor wild-type non-small cell lung cancer under the guidance of molecular markers].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheng Huang Research Topics

Disease

177Neoplasms (Cancer)
05/2024 - 10/2004
64Hepatocellular Carcinoma (Hepatoma)
03/2024 - 03/2005
61Inflammation (Inflammations)
04/2024 - 03/2004
50Infections
04/2024 - 03/2003
49Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 11/2007
46Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2023 - 12/2009
45Fibrosis (Cirrhosis)
03/2024 - 04/2006
38Obesity
07/2023 - 01/2008
28Body Weight (Weight, Body)
01/2023 - 11/2006
23Insulin Resistance
10/2022 - 01/2008
21Neoplasm Metastasis (Metastasis)
05/2024 - 02/2009
19Non-alcoholic Fatty Liver Disease
03/2024 - 04/2011
18Breast Neoplasms (Breast Cancer)
01/2023 - 01/2012
17Rheumatoid Arthritis
06/2024 - 03/2013
17Liver Diseases (Liver Disease)
03/2024 - 11/2007
16Carcinogenesis
01/2022 - 02/2008
15Disease Progression
02/2024 - 12/2009
14Lung Neoplasms (Lung Cancer)
11/2023 - 09/2014
14Fatty Liver
05/2023 - 09/2013
13Pain (Aches)
04/2024 - 10/2003
12Necrosis
07/2023 - 08/2010
12Alcoholic Fatty Liver
07/2023 - 06/2012
11Glioma (Gliomas)
11/2023 - 01/2014
11COVID-19
01/2023 - 01/2020
11Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2023 - 07/2014
10Acute Kidney Injury (Acute Renal Failure)
02/2024 - 01/2016
10Carcinoma (Carcinomatosis)
01/2023 - 01/2014
10Hyperglycemia
01/2022 - 07/2010
9Virus Diseases (Viral Diseases)
12/2023 - 04/2008
9Neuralgia (Stump Neuralgia)
01/2023 - 09/2004
9Arthritis (Polyarthritis)
01/2023 - 01/2013
9Atherosclerosis
01/2022 - 01/2016
9Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 01/2009
8Adenocarcinoma of Lung
05/2024 - 03/2014
8Hypoxia (Hypoxemia)
04/2024 - 01/2013
8Neuroinflammatory Diseases
10/2023 - 10/2017
8Brain Ischemia (Cerebral Ischemia)
02/2023 - 01/2003
8Pathologic Processes
01/2023 - 05/2013
8Liver Failure
12/2022 - 01/2019
8Type 2 Diabetes Mellitus (MODY)
10/2022 - 01/2009
7Liver Neoplasms (Liver Cancer)
03/2024 - 12/2013
7Wounds and Injuries (Trauma)
12/2023 - 06/2018
7Thrombosis (Thrombus)
11/2023 - 04/2006
7Neuroblastoma
05/2022 - 01/2017
7Hypertension (High Blood Pressure)
11/2021 - 09/2012
6Glioblastoma (Glioblastoma Multiforme)
05/2024 - 10/2020

Drug/Important Bio-Agent (IBA)

86Proteins (Proteins, Gene)FDA Link
03/2024 - 09/2003
58Biomarkers (Surrogate Marker)IBA
02/2024 - 03/2005
32MicroRNAs (MicroRNA)IBA
08/2022 - 12/2012
30CytokinesIBA
05/2024 - 08/2010
27LipidsIBA
01/2023 - 01/2009
23Messenger RNA (mRNA)IBA
03/2024 - 01/2003
23Therapeutic UsesIBA
01/2023 - 02/2005
23Glucose (Dextrose)FDA LinkGeneric
02/2022 - 01/2008
20Cisplatin (Platino)FDA LinkGeneric
02/2023 - 10/2012
17AntioxidantsIBA
04/2024 - 06/2012
16Circular RNAIBA
02/2024 - 01/2018
16Long Noncoding RNAIBA
11/2023 - 11/2014
15VaccinesIBA
01/2024 - 01/2005
15Blood Glucose (Blood Sugar)IBA
01/2022 - 07/2010
14CateninsIBA
02/2024 - 12/2013
14DNA (Deoxyribonucleic Acid)IBA
12/2023 - 06/2014
14Antiviral Agents (Antivirals)IBA
11/2023 - 02/2007
14InterferonsIBA
01/2023 - 01/2012
13RNA (Ribonucleic Acid)IBA
11/2023 - 11/2009
12AntibodiesIBA
05/2024 - 09/2013
12Interleukin-6 (Interleukin 6)IBA
01/2024 - 01/2003
12CholesterolIBA
11/2023 - 01/2012
12Insulin (Novolin)FDA Link
03/2021 - 07/2010
11CollagenIBA
05/2023 - 02/2010
11hesperetinIBA
10/2022 - 01/2013
11Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2021 - 01/2008
10Gefitinib (Iressa)FDA Link
11/2021 - 08/2010
9GemcitabineFDA Link
01/2024 - 10/2012
9Ethanol (Ethyl Alcohol)IBA
05/2023 - 12/2011
8Tyrosine Kinase InhibitorsIBA
03/2024 - 03/2014
8lenvatinibIBA
02/2024 - 03/2021
8Carbon Tetrachloride (Tetrachloromethane)IBA
07/2023 - 12/2015
8Alanine Transaminase (SGPT)IBA
01/2023 - 02/2010
8ErbB Receptors (EGF Receptor)IBA
01/2021 - 09/2013
8Triglycerides (Triacylglycerol)IBA
12/2020 - 01/2012
7LigandsIBA
05/2024 - 06/2016
7Immune Checkpoint InhibitorsIBA
02/2024 - 10/2017
7Histones (Histone)IBA
10/2023 - 09/2015
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 08/2013
7Interferon Type IIBA
01/2023 - 01/2012
7ChemokinesIBA
10/2022 - 09/2007
7CalciumIBA
10/2022 - 03/2010
7Transcription Factors (Transcription Factor)IBA
06/2022 - 09/2014
7LDL CholesterolIBA
06/2017 - 01/2012
7oxidized low density lipoproteinIBA
08/2016 - 01/2008
6Caspase 3 (Caspase-3)IBA
05/2024 - 09/2012
6Hyaluronic Acid (Hyaluronan)IBA
05/2024 - 02/2010

Therapy/Procedure

113Therapeutics
05/2024 - 02/2009
53Drug Therapy (Chemotherapy)
05/2024 - 08/2010
16Immunotherapy
04/2024 - 06/2018
13Hepatectomy
05/2023 - 09/2017
11Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2009
9Electroacupuncture
01/2021 - 03/2004
7Radiotherapy
01/2024 - 01/2016